Ad
NERV Quote Trading Chart Minerva Neurosciences Inc
home / stock / nerv / nerv quote
$3.105 Last:
22.42% Change Percent:
$3.4 Open:
$2.5364 Previous Close:
$3.4 High:
$3.06 Low:
103,971 Volume:
12/31/1969 07:00:00 pm Last Trade Date Time:
Quotes are delayed by 15 to 20 minutes.
NERV Last Five Trading Days
| Stock Date | Open Price | Close Price | High | Low | Volume |
|---|---|---|---|---|---|
| 2022-08-19 | 3.4 | 2.5364 | 3.4 | 3.06 | 103,971 |
| 2022-08-18 | 3.28 | 2.5364 | 3.67 | 3.2501 | 464,693 |
| 2022-08-17 | 3.15 | 2.5364 | 3.52 | 3.01 | 320,177 |
| 2022-08-16 | 3.1 | 2.5364 | 3.2 | 3.0001 | 125,214 |
| 2022-08-15 | 3.1 | 2.5364 | 3.33 | 3.06 | 285,716 |
| 2022-08-12 | 3.38 | 2.5364 | 3.6 | 3.1096 | 295,766 |
| 2022-08-11 | 3.4 | 2.5364 | 3.4 | 3.15 | 193,214 |
| 2022-08-10 | 3.74 | 2.5364 | 3.74 | 3.29 | 337,841 |
| 2022-08-09 | 4.38 | 2.5364 | 4.54 | 3.6 | 509,550 |
| 2022-08-08 | 4.78 | 2.5364 | 5.04 | 4.58 | 584,165 |
| 2022-08-05 | 3.99 | 2.5364 | 5.3729 | 3.82 | 2,041,491 |
| 2022-08-04 | 3.02 | 2.5364 | 7.15 | 2.85 | 37,629,023 |
| 2022-08-03 | 2.7653 | 2.5364 | 2.7653 | 2.62 | 28,775 |
| 2022-08-02 | 2.54 | 2.5364 | 2.79 | 2.54 | 35,817 |
| 2022-08-01 | 2.71 | 2.5364 | 2.71 | 2.5338 | 11,336 |
| 2022-07-29 | 2.6307 | 2.5364 | 2.71 | 2.63 | 5,192 |
| 2022-07-28 | 2.5364 | 2.5364 | 2.7086 | 2.53 | 11,398 |
| 2022-07-26 | 2.5155 | 2.5155 | 2.76 | 2.5155 | 15,569 |
| 2022-07-19 | 2.7595 | 2.86 | 2.9885 | 2.7595 | 15,829 |
| 2022-07-18 | 3.01 | 2.79 | 3.07 | 2.72 | 51,772 |
Minerva Neurosciences Inc Company Name:
NERV Stock Symbol:
NASDAQ Market:
Minerva Neurosciences Inc Website:
News, Short Squeeze, Breakout and More Instantly...
Ad
Ad
-
WALTHAM, Mass., Aug. 09, 2022 (GLOBE NEWSWIRE) -- Minerva Neurosciences, Inc. (Nasdaq: NERV), a clinical-stage biopharmaceutical company focused on the development of therapies to treat central nervous system (CNS) disorders, today reported key business updates and financial results for...
-
WALTHAM, Mass., May 04, 2022 (GLOBE NEWSWIRE) -- Minerva Neurosciences, Inc. (Nasdaq: NERV), a clinical-stage biopharmaceutical company focused on the development of therapies to treat central nervous system (CNS) disorders, today reported key business updates and financial results for the ...
-
WALTHAM, Mass., April 07, 2022 (GLOBE NEWSWIRE) -- Minerva Neurosciences, Inc. (NASDAQ: NERV), a clinical-stage biopharmaceutical company developing therapies to treat central nervous system (CNS) disorders, announced today that it has received the official meeting minutes from the Type...
Ad
